@article{fed479efc1db4361bf5952ba22d21223,
title = "Suggestive evidence of associations between liver X receptor β polymorphisms with type 2 diabetes mellitus and obesity in three cohort studies: HUNT2 (Norway), MONICA (France) and HELENA (Europe)",
keywords = "Genetic Predisposition to Disease, Introns, Orphan Nuclear Receptors/genetics, Europe, Humans, Middle Aged, Genotype, Male, Sequence Analysis, DNA, Hepatocyte Nuclear Factor 4/metabolism, Obesity/genetics, Diabetes Mellitus, Type 2/genetics, NFI Transcription Factors/metabolism, Norway, Liver X Receptors, Adolescent, Alleles, Adult, Female, Aged, Polymorphism, Single Nucleotide, France, Binding Sites, Cohort Studies",
author = "Karianne Solaas and Vanessa Legry and Kjetil Retterstol and Berg, \{Paul R.\} and Holven, \{Kirsten B.\} and Jean Ferri{\`e}res and Philippe Amouyel and Sigbjorn Lien and Javier Romeo and Jara Valtue{\~n}a and Kurt Widhalm and Ruiz, \{Jonatan R.\} and Jean Dallongeville and Serena Tonstad and Helge Rootwelt and Bente Halvorsen and Nenseter, \{Marit S.\} and Birkeland, \{Kare I.\} and Thorsby, \{Per M.\} and Aline Meirhaeghe and Nebb, \{Hilde I.\}",
note = "Funding Information: The HUNT2 Study is collaboration between the HUNT Research Centre, Faculty of Medicine, Norwegian University of Science and Technology, Norwegian Institute of Public Health, and Nord-Tr{\o}ndelag County Council. We thank Nina Gjerlaugsen and Kristil Kindem Sundsaasen for excellent laboratory work. We thank Dr R. Gronostajski (Buffalo, NY, USA) for providing us with the NF1 expression vectors. The work was supported by the Norwegian Research Council [grant number 101114/310] {\textquoteleft}to [KS] and [MSN]{\textquoteright}; South-Eastern Norway Regional Health Authority [grant number AUS 2007-25] {\textquoteleft}to [KS]{\textquoteright}; the Institut Pasteur de Lille {\textquoteleft}to [VL]{\textquoteright}; the Institut National de la Sant{\'e} et de la Recherche M{\'e}dicale (INSERM); the Conseil R{\'e}gional du Nord-Pas de Calais, ONIVINS; the Parke-Davis Laboratory, the Mutuelle G{\'e}n{\'e}rale de l{\textquoteright}Education Nationale (MGEN); the Groupe Fournier, the R{\'e}seau National de Sant{\'e} Publique; the Direction G{\'e}n{\'e}rale de la Sant{\'e}, the Institut Pasteur de Lille; and the Unit{\'e} d{\textquoteright}Evaluation du Centre Hospitalier et Universitaire de Lille. The HELENA Study was funded by the European Union{\textquoteright}s Sixth RTD Framework Programme [grant number Contract FOOD-CT-2005-007034]; Universidad Polit{\'e}cnica de Madrid [grant number CH/018/2008]; Axis-Shield Diagnostics Ltd (Oslo, Norway); Abbot Cient{\'i}fica S.A. (Spain); the Spanish Ministry of Education [EX-2007-1124], and Cognis GmbH (Germany). The present study was part of CRESCENDO (Consortium for Research into Nuclear Receptors in Development and Aging) funded by the Commission{\textquoteright}s Sixth Framework Programme [grant number LSHM-CT-2005-018652].",
year = "2010",
month = oct,
day = "12",
doi = "10.1186/1471-2350-11-144",
language = "English",
volume = "11",
journal = "BMC Medical Genetics",
issn = "1471-2350",
number = "1",
}